Skip to main content
Fig. 1 | SpringerPlus

Fig. 1

From: Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria

Fig. 1

Schematic model structure (ER/PR + : estrogen and/or progesterone receptor positive, LY: life years, QALY: quality adjusted life years, ADE: adverse drug event, Int.: intermediate, AO: Adjuvant!Online, ODX: OncotypeDX, N/A: not applied) Source: Jahn et al. (2015). Lessons Learned from a Cross-Model Validation between a Discrete Event Simulation Model and a Cohort State-Transition Model for Personalized Breast Cancer Treatment. Medical Decision Making (published ahead of print). Copyright © 2015 by Society for Medical Decision Making. Reprinted by permission of SAGE Publications, Inc.

Back to article page